BMO Capital Upgrades CVS Caremark (CVS) to Outperform

Article Stock Quotes (1) Comments (0)

BMO Capital upgraded CVS Caremark (NYSE: CVS) from Market Perform to Outperform with a price target of $53.00 (from $47.00).

For an analyst ratings summary and ratings history on CVS Caremark click here. For more ratings news on CVS Caremark click here.

Shares of CVS Caremark closed at $44.12 yesterday, with a 52 week range of $31.30-$48.69.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
• RBC Capital Upgrades U.S. Silica Holdings (SLCA) to Outperform
• Wells Fargo Upgrades Rosetta Resources (ROSE) to Outperform, Shares Attractive

Create E-mail Alert Related Categories

Upgrades

Related Entities

BMO Capital

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?